Dec 19 (Reuters) - Allergan (NYSE:AGN) plc AGN.N :
* ALLERGAN SUSPENDS SALES AND WITHDRAWS SUPPLY OF TEXTURED BREAST IMPLANTS IN EUROPEAN MARKETS
* ALLERGAN PLC - WITHDRAWAL DECISION FOLLOWS A COMPULSORY RECALL REQUEST FROM AGENCE NATIONALE DE SÉCURITÉ DU MÉDICAMENT
* ALLERGAN PLC - WILL CONTINUE TO WORK THROUGH CE MARK RENEWAL WITH GMED
* ALLERGAN PLC - SUSPENSION OF SALES STEMS FROM EXPIRATION OF COMPANY'S CE MARK FOR THESE PRODUCTS
* ALLERGAN PLC - ALTHOUGH ALLERGAN DISAGREES WITH ANSM'S REQUEST, COMPANY IS FULLY COOPERATING WITH AUTHORITY
* ALLERGAN PLC - "ALLERGAN STANDS BEHIND THE BENEFIT/RISK PROFILE OF OUR BREAST IMPLANT PRODUCTS"
* ALLERGAN PLC - ANSM HAS NOT IDENTIFIED ANY IMMEDIATE RISK TO HEALTH OF WOMEN WITH TEXTURED BREAST IMPLANTS
* ALLERGAN PLC - PLANNING AN APPEAL TO ENSURE APPROPRIATE PATIENTS HAVE ACCESS TO PRODUCTS THAT THEIR SURGEONS RECOMMEND
* ALLERGAN PLC - SMOOTH IMPLANTS ARE NOT AFFECTED AND CONTINUE TO BE AVAILABLE FOR PATIENTS
* ALLERGAN PLC - UNITED STATES DOES NOT REQUIRE CE MARK SO IT IS UNAFFECTED BY ACTION
* ALLERGAN PLC - ANSM REQUEST, AND ACTION TO SUSPEND SALES, IS "NOT BASED ON ANY NEW SCIENTIFIC EVIDENCE REGARDING THESE PRODUCTS"
* ALLERGAN - ANSM REQUEST, AND SUSPENSION OF SALES OF TEXTURED BREAST IMPLANTS & TISSUE EXPANDERS, IS NOT BASED ON ANY NEW SCIENTIFIC EVIDENCE